Cargando…
Use of Repository Corticotropin Gel (Acthar) in Progressive Nephrotic Syndrome Secondary to Transplant Glomerulopathy: A Report of Three Cases
Transplant glomerulopathy is a feared complication of kidney transplantation, often resulting in rapid loss of kidney function and ultimate graft failure. The underlying cause is unclear, with both antibody and cell-mediated immune mechanisms postulated, as well as intrinsic glomerular factors. At t...
Autores principales: | Markell, Mariana, Brar, Amarpali, Bhela, Serena, Patel, Ankita, Salifu, Moro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7380415/ https://www.ncbi.nlm.nih.gov/pubmed/32734181 http://dx.doi.org/10.1016/j.xkme.2018.12.003 |
Ejemplares similares
-
H.P. Acthar Gel (repository corticotropin injection) treatment of patients with multiple sclerosis and diabetes
por: Kutz, Christen
Publicado: (2016) -
A Prospective Observational Registry of Repository Corticotropin Injection (Acthar® Gel) for the Treatment of Multiple Sclerosis Relapse
por: Kaplan, Jeffrey, et al.
Publicado: (2020) -
Membranous glomerulopathy and treatment with Acthar®: a case study
por: Watson, Myra June
Publicado: (2013) -
Repository Corticotropin Injection (Acthar(®) Gel) for Refractory Severe Noninfectious Keratitis: Efficacy and Safety from a Phase 4, Multicenter, Open-Label Study
por: Wirta, David, et al.
Publicado: (2021) -
Acthar gel in the treatment of nephrotic syndrome: a multicenter retrospective case series
por: Madan, Arvind, et al.
Publicado: (2016)